Drug Type Interferons, Biosimilar |
Synonyms Interferon alfa-2a, recombinant Biosimilar (LG Life Sciences Ltd.), 干扰素α-2a生物类似药(LG Life Sciences Ltd.), Intermax Alpha |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (31 Dec 1992), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hairy Cell Leukemia | KR | 31 Dec 1992 | |
Hepatitis B | KR | 31 Dec 1992 | |
Hepatitis C | KR | 31 Dec 1992 | |
Kaposi Sarcoma | KR | 31 Dec 1992 | |
Melanoma | KR | 31 Dec 1992 | |
Multiple Myeloma | KR | 31 Dec 1992 | |
Philadelphia chromosome positive chronic myelogenous leukemia | KR | 31 Dec 1992 | |
Renal Cell Carcinoma | KR | 31 Dec 1992 |